Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Z9Y95 | — |
Administration without diluent.; Administration without diluent.; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate preparation of medication in a 1-year-old female patient who received Hib (Hiberix) (batch number Z9Y95, expiry date 20-OCT-2026) for prophylaxis. On 27-AUG-2025, the patient received Hiberix. On 27-AUG-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Administration without diluent.) and inappropriate dose of vaccine administered (Verbatim: Administration without diluent.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-AUG-2025 The physician reported that the patient who were mistakenly given the Hiberix vaccine without diluent and they weren't given the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered This was 1 of the 3 cases, reported by the same reporter.; Sender's Comments: US-GSK-US2025111045:Same reporter, Different patient US-GSK-US2025111058:Same reporter, Different patient